Of the 40 recertification units (RUs) required for a CRNI® to recertify, at least 30 RUs must be earned through eligible live or online education designated as Core Education RUs. Up to 10 additional RUs may be earned through the Flexible RUs category. All learning assets in this section have been approved for RUs. Virtual Conferences qualify as Core Education RUs, while webinars qualify as Flexible RUs. All webinars are free to INS members.

CRNI® Recertification Approved

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Keyword
  • Contains 1 Component(s) Includes a Live Web Event on 10/28/2026 at 1:00 PM (EDT)

    Connect with INS leadership for a look at the work advancing our mission and supporting the infusion nursing community. We’ll share highlights from 2026, including education and member engagement, partnerships, operational improvements, and financials. We’ll also look ahead to the January 2027 launch of the 10th edition of the Infusion Therapy and Vascular Access Standards of Practice, upcoming educational opportunities, and initiatives supporting INS’s continued growth. Join us to stay informed and learn what’s ahead for your professional community.

    Connect with INS leadership for a look at the work advancing our mission and supporting the infusion nursing community. We’ll share highlights from 2026, including education and member engagement, partnerships, operational improvements, and financials. We’ll also look ahead to the January 2027 launch of the 10th edition of the Infusion Therapy and Vascular Access Standards of Practice, upcoming educational opportunities, and initiatives supporting INS’s continued growth.

    Join us to stay informed and learn what’s ahead for your professional community.

    Have a question you would like INS leadership to address during the Town Hall? Submit your question here.

    Amber Webb, MSN-HI, RN, CRNI®

    Amber Webb, MSN-HI, RN, CRNI®

    President

    INS

    Amber Webb, MSN-HI, RN, CRNI®, is the Nurse Manager for Home Infusion Pharmacy and Ambulatory Non-Oncology Infusion at Oregon Health and Science University based in Portland, OR. Her background includes extensive experience in hematologic malignancies with practice expertise in stem cell transplant and chimeric antigen receptor T-cell (CAR-T) therapies. Her current role is dynamic, overseeing 2 licensed clinical spaces and another team of home infusion nurses spanning 2 states (OR/WA). Professionally, Amber aims to strengthen the profession of infusion nursing through strong collaboration and outreach, while paying specific attention to nurse safety – regardless of practice setting. She wears many leadership hats within her organization as well as being the President of the Board of Directors for the Infusion Nurses Society.

    Andrew A. Walker, BSN, RN, CRNI®, VA-BC™

    Andrew A. Walker, BSN, RN, CRNI®, VA-BC™

    Secretary-Treasurer

    INS

    Andrew A. Walker, BSN, RN, VA-BC, CRNI®, is the Clinical Practice Leader for Vascular Access and Infusion Therapy at UnityPoint Health–Meriter Hospital in Madison, Wisconsin. His prior roles include critical care and vascular access nursing at Meriter and medical-surgical nursing at UW Health–The American Center. He leads quality improvement, staff education, and infusion safety initiatives and serves as Secretary/Treasurer on the Infusion Nurses Society Board of Directors. Andrew is pursuing a Doctor of Nursing Practice degree in the Adult-Gerontology Clinical Nurse Specialist program at the University of Wisconsin–Milwaukee.

    Chris Hunt, MBA

    Chris Hunt, MBA

    Chief Executive Officer

    INS

    Chris Hunt, MBA, serves as the Chief Executive Officer of INS and INCC. In this role, Chris works with the executive management team to develop strategies for new business development and overall organizational growth. Chris began his INS career in 1995 when INS did not have e-mail or the internet and people had to use a telephone to communicate. He held positions as meetings manager, director of meetings, director of marketing, and executive vice president before assuming his current position as CEO in May 2023.

    Maria Connors, MBA, CAE

    Maria Connors, MBA, CAE

    Chief Operating Officer

    INS

    Maria Connors, MBA, CAE. As part of the INS executive team, Maria is responsible for maximizing the operational performance of the Infusion Nurses Society (INS) and the Infusion Nurses Certification Corporation (INCC) and achieving each organization’s financial goals. In addition, she works to implement the strategic view and initiatives of both organizations, as set forth by the board of directors, and helps ensure that all mission objectives are met. Maria is also responsible for all human resource initiatives and key performance indicators.

    Maria completed her MBA program with a specialization in Human Resource Management. She also sat for and passed the CAE exam and was awarded the designation of Certified Association Executive. When not working, Maria’s favorite role is that of Nonnie to her 2 beautiful grandchildren.

    Marlene Steinheiser, PhD, RN, CRNI®, FAAN

    Marlene Steinheiser, PhD, RN, CRNI®, FAAN

    Chief Clinical Officer

    INS

    Marlene Steinheiser, PhD, RN, CRNI®, FAAN, Chief Clinical Officer at INS, is responsible for supporting the vision and mission of the organization nationally and globally, which includes strategic planning and development of new programs, research, and education. With 39 years of nursing experience, she has been a CRNI® since 1991. Her background includes work in diverse clinical settings, faculty roles in both pre-licensure and post-licensure nursing education, and service as a nurse practice consultant for a state nursing regulatory board. Her passion for infusion therapy and vascular access has been integrated into each of her varied career roles.

    Dr Steinheiser holds a PhD from the University of Arizona, a master’s degree and a Bachelor of Science in nursing from the University of Akron, and a nursing diploma from Cleveland Metropolitan General Hospital School of Nursing. She conducts research on infusion therapy, vascular access, and compassion fatigue in nursing, with a particular interest in mixed methods research and qualitative data analysis. She also presents nationally and internationally on infusion therapy and vascular access topics.

    Meghan Trupiano, MBA, CMP

    Meghan Trupiano, MBA, CMP

    Director of Conferences & Member Services

    INS

    Meghan Trupiano, MBA, CMP, serves as the Director of Conferences & Member Services, leading the strategy, planning, and execution of programs that strengthen member engagement and support the organization’s mission. She oversees the INS Annual Meeting and Virtual Conferences, managing all aspects of meeting logistics, hotel and vendor relations, and exhibit and sponsorship sales. In addition, Meghan plays a key role in developing and executing marketing and communication plans that promote INS programs and membership growth.

    Meghan earned her MBA from Curry College and is a Certified Meeting Professional (CMP). She lives in Massachusetts with her husband and their 3 young boys. Outside of work, she enjoys spending time with her family and unwinding with a good book.

  • Contains 3 Component(s), Includes Credits

    Building upon foundational concepts, this session will explore real-world applications of artificial intelligence (AI) within infusion therapy and vascular access practice. Topics will include AI-enhanced clinical decision support, smart infusion pumps, chatbots, predictive technologies, workflow optimization, and the opportunities and challenges associated with bedside implementation.

    image

    Building upon foundational concepts, this session will explore real-world applications of artificial intelligence (AI) within infusion therapy and vascular access practice. Topics will include AI-enhanced clinical decision support, smart infusion pumps, chatbots, predictive technologies, workflow optimization, and the opportunities and challenges associated with bedside implementation.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1. Identify current and emerging applications of artificial intelligence in infusion therapy and vascular access practice, including clinical decision support, smart infusion technologies, predictive tools, and workflow optimization. 
    2. Describe how AI-enabled technologies can support clinical decision-making, patient safety, and efficiency across infusion therapy workflows. 
    3. Evaluate opportunities, limitations, and implementation considerations associated with integrating AI-enabled technologies into bedside clinical practice.

    Jane Carrington, PhD, RN, FAMIA, FAAN

    Jane Carrington, PhD, RN, FAMIA, FAAN

    Jane Carrington, PhD, RN, FAMIA, FAAN, has over 26 years of experience as an analyst, scientist, and educator. She has worked to advance technology and artificial intelligence (AI) in nursing. Her emphasis is the electronic health record as a communication system and data guiding health care decision-making. She has emerged as a leader in nursing-education, health care, and artificial intelligence. Dr Carrington has been working to assist nursing programs to achieve success in faculty understanding AI, it's application in nursing education, and preparation of nursing students for the challenges in working with advancing technology.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 21, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits

    Selecting the appropriate infusion flow-control device requires an understanding of infusion pump technology capabilities and the needs of the clinical systems in which they are used for infusion therapy. This session provides a foundational overview of factors that influence flow-control device selection, key infusion pump safety features, and the role of smart pumps and dose-error reduction systems (DERS) in supporting medication safety. Participants will explore device technology differences, drug library configuration, dead volume, management of fluid container overfill, how administration set and accessory design can contribute to medication errors, and clinical sources and implications for dosing accuracy. Through evidence-based discussion and case study examples, learners will build a systems-based understanding of how infusion technology, clinical practice and organizational safety strategies work together to promote safe, accurate, and effective infusion therapy.

    image

    Selecting the appropriate infusion flow-control device requires an understanding of infusion pump technology capabilities and the needs of the clinical systems in which they are used for infusion therapy. This session provides a foundational overview of factors that influence flow-control device selection, key infusion pump safety features, and the role of smart pumps and dose-error reduction systems (DERS) in supporting medication safety.

    Participants will explore device technology differences, drug library configuration, dead volume, management of fluid container overfill, how administration set and accessory design can contribute to medication errors, and clinical sources and implications for dosing accuracy. Through evidence-based discussion and case study examples, learners will build a systems-based understanding of how infusion technology, clinical practice and organizational safety strategies work together to promote safe, accurate, and effective infusion therapy.

     Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Explain factors used to select the appropriate flow-control device for infusion therapy
    • Identify essential infusion pump safety features that support safe medication delivery
    • Describe the role of smart pumps for reducing infusion-related medication errors and adverse drug events
    • Evaluate flow rate accuracy, dead volume and fluid container overfill and explore their implications on medication and fluid delivery
    • Identify how administration-set design and accessory devices contribute to dead volume and influence medication delivery

    Jeannine Blake, PhD, RN

    Jeannine Blake, PhD, RN

    Assistant Professor

    University of Massachusetts Amherst

    Jeannine Blake, PhD, RN, is a nurse scientist with a clinical background in surgical intensive care nursing and a passion for advancing health care innovation using an interdisciplinary nurse-engineer approach. Her research focuses on improving intravenous (IV) pumping technology accuracy, flow steadiness, usability, and reducing alarm burden on nurses and patients. She is dedicated to improving patient outcomes, streamlining nursing workflows, and integrating IV pumps more effectively into real-world clinical practices.

    Dr Blake earned her PhD in Nursing Science and completed a Postdoctoral Research Fellowship in Engineering at the University of Massachusetts Amherst. She is now an Assistant Professor in the Elaine Marieb College of Nursing and is affiliated with the Elaine Marieb Center for Nursing and Engineering Innovation.

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN

    Clinical Nurse Specialist

    The James Cancer Hospital at The Ohio State Wexner Medical Center

    Karen Meade, MS, APRN-CNS, AGCNS-BC, OCN, is a Clinical Nurse Specialist at The Ohio State University Wexner Medical Center, where her work focuses on advancing safe, evidence-based infusion therapy practices. Her clinical and scholarly interests include intravenous smart pump technology, medication delivery, infusion system design, and the ways nurses interact with infusion devices in complex care environments. Ms Meade has presented nationally on considerations and limitations associated with intravenous smart pump medication administration and the implications of infusion technology for patient safety. Karen is also a doctoral student at the University of Massachusetts Amherst, where her research examines the use of intravenous smart pump-generated data to better understand alarm phenomena, nurse-pump interactions, and opportunities to improve the safety and effectiveness of infusion therapy.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 23, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits

    As artificial intelligence (AI) continues to transform health care delivery, clinicians must first understand the fundamentals before safely applying these technologies in practice. This session will provide a practical introduction to artificial intelligence, machine learning, generative AI, and emerging technologies shaping the future of patient care.

    image

    As artificial intelligence (AI) continues to transform health care delivery, clinicians must first understand the fundamentals before safely applying these technologies in practice. This session will provide a practical introduction to artificial intelligence, machine learning, generative AI, and emerging technologies shaping the future of patient care.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Describe the data pathway from point of entry to storage to extraction for measuring patient outcomes 
    • Explain the process of building on data to artificial intelligence
    • Discuss the applications that are the result of the process of data to artificial intelligence
    • Discuss introduction to artificial intelligence in health care and nursing

    Jane Carrington, PhD, RN, FAMIA, FAAN

    Jane Carrington, PhD, RN, FAMIA, FAAN

    Jane Carrington, PhD, RN, FAMIA, FAAN, has over 26 years of experience as an analyst, scientist, and educator. She has worked to advance technology and artificial intelligence (AI) in nursing. Her emphasis is the electronic health record as a communication system and data guiding health care decision-making. She has emerged as a leader in nursing-education, health care, and artificial intelligence. Dr Carrington has been working to assist nursing programs to achieve success in faculty understanding AI, it's application in nursing education, and preparation of nursing students for the challenges in working with advancing technology.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 19, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits

    Medication administration errors (MAEs) remain a leading cause of preventable patient harm and are a significant concern in outpatient infusion settings where nurses often assume primary responsibility for medication preparation, verification, administration, and patient education. As infusion services continue to expand, organizations need practical and sustainable strategies to strengthen medication safety and reduce the risk of errors associated with high-risk intravenous therapies. This comprehensive practice-focused session will examine common system and human factors contributing to MAEs, review the implementation of a structured Medication Administration Evaluation and Feedback Tool (MAEFT), and present outcomes from a multi-site outpatient infusion quality improvement initiative. Participants will gain practical approaches for applying observation, feedback, and procedural safety practices to improve adherence to medication administration standards and support a culture of safety. In this session, we will explore medication safety risks in outpatient infusion practice, discuss implementation of the MAEFT framework, and identify strategies that infusion nurses can use to improve medication administration safety and patient outcomes.

    Medication administration errors (MAEs) remain a leading cause of preventable patient harm and are a significant concern in outpatient infusion settings where nurses often assume primary responsibility for medication preparation, verification, administration, and patient education. As infusion services continue to expand, organizations need practical and sustainable strategies to strengthen medication safety and reduce the risk of errors associated with high-risk intravenous therapies. This comprehensive practice-focused session will examine common system and human factors contributing to MAEs, review the implementation of a structured Medication Administration Evaluation and Feedback Tool (MAEFT), and present outcomes from a multi-site outpatient infusion quality improvement initiative. Participants will gain practical approaches for applying observation, feedback, and procedural safety practices to improve adherence to medication administration standards and support a culture of safety. In this session, we will explore medication safety risks in outpatient infusion practice, discuss implementation of the MAEFT framework, and identify strategies that infusion nurses can use to improve medication administration safety and patient outcomes.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1. Describe common system and human factors contributing to medication administration errors in outpatient infusion settings 
    2. Explain how structured observation and feedback strategies can be used to improve medication administration safety and clinician adherence to best practices 
    3. Discuss the implementation and application of the Medication Administration Evaluation and Feedback Tool (MAEFT) to strengthen medication safety practices in outpatient infusion clinics

    Valerie Brady, DNP, MSN-Ed, APRN, FNP-C

    Valerie Brady, DNP, MSN-Ed, APRN, FNP-C

    Valerie Brady, DNP, MSN-Ed, APRN, FNP-C, is a Family Nurse Practitioner, nurse educator, and health care leader with more than 25 years of nursing experience spanning pediatrics, oncology, emergency care, labor and delivery, infusion therapy, and nursing education. She currently serves as an Instructor Faculty Associate at Arizona State University and has held leadership roles in outpatient infusion practice, including serving as Clinical Education Manager and Family Nurse Practitioner for a multi-state infusion organization, where she provided clinical oversight, onboarding, competency development, and continuing education for more than 200 clinicians across 6 states. In addition to her academic and clinical practice roles, Dr Brady currently consults with an outpatient infusion organization on clinical operations, education, and quality improvement initiatives. She recently completed her Doctor of Nursing Practice degree at Northern Arizona University, focusing on medication safety in outpatient infusion clinics. Dr Brady’s combined clinical, leadership, consulting, and academic experience provides a unique perspective on advancing medication safety and quality improvement in infusion nursing practice.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 29, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits

    Hereditary Hemochromatosis (HH), a genetic condition characterized by excessive iron accumulation, is prevalent among Northern European populations, causes excessive iron accumulation, and requires regular therapeutic phlebotomy (blood removal) for treatment. Despite critical global blood shortages, this blood is often discarded based on outdated safety concerns. A rapid review of literature was conducted to assess the safety and effectiveness of using blood from uncomplicated HH patients. The review found strong evidence that blood from HH donors is safe, effective, and comparable to that of healthy donors. Specifically, red blood cells from HH donors improve hemoglobin increments in transfusion recipients, and their platelet quality is comparable to healthy donors. This evidence strongly supports updating policies to integrate HH patients into the general blood supply and mitigate the professional liability associated with the unnecessary waste of a valuable medical resource.

    Hereditary Hemochromatosis (HH), a genetic condition characterized by excessive iron accumulation, is prevalent among Northern European populations, causes excessive iron accumulation, and requires regular therapeutic phlebotomy (blood removal) for treatment. Despite critical global blood shortages, this blood is often discarded based on outdated safety concerns. A rapid review of literature was conducted to assess the safety and effectiveness of using blood from uncomplicated HH patients. The review found strong evidence that blood from HH donors is safe, effective, and comparable to that of healthy donors. Specifically, red blood cells from HH donors improve hemoglobin increments in transfusion recipients, and their platelet quality is comparable to healthy donors. This evidence strongly supports updating policies to integrate HH patients into the general blood supply and mitigate the professional liability associated with the unnecessary waste of a valuable medical resource. 

    Learning Objectives: At the conclusion of this session, learners will be able to:
    • Explain the clinical necessity of therapeutic phlebotomy for hemochromatosis patients and the global blood supply implications of discarding this blood. 
    • Analyze the safety and efficacy data of blood collected from uncomplicated HH patients, as evidenced by a rapid review of the literature. 
    • Compare the quality of key blood components (red cells and platelets) from HH donors against those from healthy donors. 
    • Justify policy changes and propose strategies to safely integrate uncomplicated HH patients into standard blood donation programs. 

    Fatima Karashi, MSN, BSN, RN

    Fatima Karashi, MSN, BSN, RN

    Fatima Karashi, MSN, BSN, RN, has a master’s degree in Nursing Leadership and Management, with experience in ambulatory and specialty care, nursing leadership, quality improvement, and evidence-based practice. Throughout her career, she has been actively involved in initiatives aimed at enhancing patient care, improving health care processes, and supporting professional development within multidisciplinary teams. Ms Karashi’s academic background and professional experience have strengthened her interest in research and the application of evidence to practice. This presentation reflects her commitment to advancing health care through evidence-informed decision-making. By synthesizing and evaluating current literature, this work seeks to provide meaningful insights that can inform clinical practice, health care policy, and future research.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 30, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 05/27/2026

    Peripheral intravenous catheter (PIVC) insertion is a routine procedure in emergency departments (EDs), yet current practice often deviates from evidence-based standards. Research highlights key issues, including unnecessary (idle) catheter insertion, overuse of antecubital fossa (ACF) sites, and limited patient involvement in decision-making. These gaps can lead to avoidable patient harm, reduced comfort, and inefficient use of resources. This intermediate-level session will provide an evidence-informed overview of these challenges and the factors driving them. In this session, we will examine the evidence–practice gap in ED PIVC care and identify practical, patient-centered strategies to improve clinical decision-making and outcomes.

    Peripheral intravenous catheter (PIVC) insertion is a routine procedure in emergency departments (EDs), yet current practice often deviates from evidence-based standards. Research highlights key issues, including unnecessary (idle) catheter insertion, overuse of antecubital fossa (ACF) sites, and limited patient involvement in decision-making. These gaps can lead to avoidable patient harm, reduced comfort, and inefficient use of resources. This intermediate-level session will provide an evidence-informed overview of these challenges and the factors driving them. In this session, we will examine the evidence–practice gap in ED PIVC care and identify practical, patient-centered strategies to improve clinical decision-making and outcomes.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Analyze the current gaps between evidence-based guidelines and real-world PIVC practices in emergency departments 
    • Evaluate the clinical, behavioral, and system-level factors contributing to suboptimal practices, including ACF insertion and idle catheter use
    • Apply evidence-based and patient-centered strategies to improve PIVC decision-making, insertion, and care in the ED setting

    Grace Xu, Phd, RN

    Grace Xu, Phd, RN

    Dr Grace (Hui) Xu, PhD, is a Nurse Practitioner at an Emergency Trauma Center in Australia and a Senior Implementation Science Research Fellow at the Queensland University of Technology. As a Clinician-Researcher, Dr Xu is dedicated to the core belief that patients in emergency departments should receive medical treatment without any associated harm.

    Her work focuses on advocating and promoting evidence-based practices in patient care, with a particular emphasis on optimizing insertions and preventing complications associated with vascular access devices in emergency settings.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: May 27, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 1 Component(s)

    INS invites you to join our partner, the Academy of Medical-Surgical Nurses (AMSN), for a free educational webinar designed for nurses at all experience levels on Peripheral IV catheter (PIVC) insertion and infusion practices.

    INS invites you to join our partner, the Academy of Medical-Surgical Nurses (AMSN), for a free educational webinar designed for nurses at all experience levels on Peripheral IV catheter (PIVC) insertion and infusion practices.

    PIVC insertion and management are essential skills across all care settings, yet practice variation and persistent myths can increase the risk of complications such as infection, phlebitis, extravasation, and occlusion. This webinar will examine common misconceptions in PIV insertion and peripherally administered infusion therapy, and present evidence-based strategies to improve patient safety and clinical outcomes.

    Presenter Details:

    Barb Nickel, APRN-CNS, CCRN, CRNI, is a nationally recognized nurse leader, educator, and researcher. Ms. Nickel is chair of the 2027 INS Standards of Practice Committee and has extensive experience in staff development, infusion therapy, and practice improvement across multiple clinical settings.

    What You’ll Learn:

    • Best practices for optimal PIVC placement
    • Aseptic technique throughout the device life span
    • Safe peripheral medication administration
    • Early recognition and prevention of common complications

    How To Register: Enter code INSWEBFREE at the bottom of the course overview page under “Apply Redeem Coupon. "Note: You will be prompted to create a free AMSN account to enroll.

    REGISTER NOW

  • Contains 3 Component(s), Includes Credits Recorded On: 04/22/2026

    Peripheral intravenous catheter (PIVC) practices often vary across clinicians and care settings, contributing to inconsistencies in care and increased risk of complications. This session will review current organizational practices and highlight common variations identified in the literature, while discussing evidence-based standards for PIVC insertion, assessment, and maintenance, including site selection, aseptic non-touch technique (ANTT®), and standardized assessment tools such as i-DECIDED. The presentation will also share results from a quality improvement initiative aimed at reducing practice variation through product standardization, insertion checklists, competency-based education, and validation audits. Outcomes related to adherence and infection prevention will be discussed, along with practical strategies for translating quality improvement results into sustainable organizational practice change.

    Peripheral intravenous catheter (PIVC) practices often vary across clinicians and care settings, contributing to inconsistencies in care and increased risk of complications. This session will review current organizational practices and highlight common variations identified in the literature, while discussing evidence-based standards for PIVC insertion, assessment, and maintenance, including site selection, aseptic non-touch technique (ANTT®), and standardized assessment tools such as i-DECIDED. The presentation will also share results from a quality improvement initiative aimed at reducing practice variation through product standardization, insertion checklists, competency-based education, and validation audits. Outcomes related to adherence and infection prevention will be discussed, along with practical strategies for translating quality improvement results into sustainable organizational practice change.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Discuss the existing concerns with PIVC practices
    • Describe the professional standards and recommendations for PIVC practice
    • Demonstrate actions to eliminate discrepancies between existing practices and professional standards
    • Apply quality improvement (QI) project results to organizational practice change 

    Kristie M. Coleman, MSN, RN, VA-BC

    Kristie M. Coleman, MSN, RN, VA-BC

    Kristie M. Coleman, MSN, RN, VA-BC’s vascular access experience began when she transitioned from critical care to a hospital peripherally inserted central catheter (PICC) team, eventually becoming a clinical lead for the team. She then moved into a vascular access team (VAT) program coordinator role with another organization. Ms Coleman’s involvement there included redefining the role and expectation of vascular access nurses, changing workflow process, changing dwell time for ultrasound-guided peripheral IVs inserted by VAT nurses, teaching, course development, updating nursing procedures, and encouraging interdepartmental and interdisciplinary collaboration. Her experience also provided the opportunity to lead a VAT that bridged into a new second hospital, expanding the system. Ms Coleman has since transitioned into her institution’s infection prevention department utilizing her vascular access background.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: April 22, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 5 Product(s)

    Join INS for Advancing Infusion Therapy: Innovation, Safety, and Best Practices, a virtual conference featuring five expert-led sessions focused on the latest advances in infusion therapy and vascular access. Explore evidence-based strategies for infection prevention, vascular access device selection, infusate compatibility, peripheral intravenous catheter care, and innovative approaches to improve patient safety and nursing efficiency. Gain practical insights and actionable strategies to enhance clinical practice and optimize patient outcomes across care settings. At the conclusion of the virtual conference, participants will be able to claim 5 contact hours and CRNI®s can earn up to 10 recertification units.

    Join INS for Advancing Infusion Therapy: Innovation, Safety, and Best Practices, a virtual conference featuring five expert-led sessions focused on the latest advances in infusion therapy and vascular access. Explore evidence-based strategies for infection prevention, vascular access device selection, infusate compatibility, peripheral intravenous catheter care, and innovative approaches to improve patient safety and nursing efficiency. Gain practical insights and actionable strategies to enhance clinical practice and optimize patient outcomes across care settings. At the conclusion of the virtual conference, participants will be able to claim 5 contact hours and CRNI®s can earn up to 10 recertification units.